Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis

Authors :: Wong, John B.
Singh, Gurkirpal
Kavanaugh, Arthur
Source :: American Journal of Medicine. Oct 1, 2002, Vol. 113 Issue 5, p400, 9 p.
Publication Year :: 2002

Subjects :: Infliximab -- Evaluation
Infliximab -- Economic aspects
Infliximab -- Dosage and administration
Rheumatoid arthritis -- Drug therapy
Health
Health care industry

Tools